Recordati SpA (REC)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Recordati SpA (REC)
Go deeper and ask any question about REC
Company Performance
Current Price
as of Sep 17, 2024$56.75
P/E Ratio
27.14
Market Cap
$11.71B
Description
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases segments. The Specialty and Primary Care segment includes pharmaceutical chemical operations. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.
Metrics
Overview
- HQMilan, MI
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerREC
- Price$56.752045+0.91%
Trading Information
- Market Cap$11.71B
- Float46.86%
- Average Daily Volume (1m)189,514
- Average Daily Volume (3m)222,796
- EPS$1.88
Company
- Revenue$2.22B
- Rev Growth (1yr)17.23%
- Net Income$101.77M
- Gross Margin66.84%
- EBITDA Margin32.87%
- EBITDA$189.96M
- EV$11.65B
- EV/Revenue5.24
- P/E27.14
- P/S4.79